1-4 of 4
Katherine Stemke-Hale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma

Free
Tuhina Mazumdar, Lauren A. Byers, Patrick Kwok Shing Ng, Gordon B. Mills, Shaohua Peng, Lixia Diao, You-Hong Fan, Katherine Stemke-Hale, John V. Heymach, Jeffrey N. Myers, Bonnie S. Glisson, Faye M. Johnson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2738–2750.
https://doi.org/10.1158/1535-7163.MCT-13-1090
Published: 03 November 2014
View articletitled, A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma
Open the PDF for A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

Free
Ana M. Gonzalez-Angulo, Jaime Ferrer-Lozano, Katherine Stemke-Hale, Aysegul Sahin, Shuying Liu, Juan A. Barrera, Octavio Burgues, Ana M. Lluch, Huiqin Chen, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 1093–1101.
https://doi.org/10.1158/1535-7163.MCT-10-1089
Published: 08 June 2011
View articletitled, PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
Open the PDF for PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer in another window
Journal Articles

Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

Free
Scott E. Woodman, Jonathan C. Trent, Katherine Stemke-Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan, Maurizio Fermeglia, Y.N. Vashisht Gopal, Dan Yang, Donald A. Podoloff, Doina Ivan, Kevin B. Kim, Nicholas Papadopoulos, Patrick Hwu, Gordon B. Mills, Michael A. Davies
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (8): 2079–2085.
https://doi.org/10.1158/1535-7163.MCT-09-0459
Published: 14 August 2009
View articletitled, Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates
Open the PDF for Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates in another window
Includes: Supplementary data
Journal Articles

Activating PIK3CA and AKT mutations in triple-receptor-negative breast cancer

Free
Ana Gonzalez-Angulo, Bryan Hennessy, Katherine Stemke-Hale, Kristine Broglio, Mark Carey, Michael Davies, Funda Meric-Bernstam, Gabriel Hortobagyi, Gordon Mills
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C42.
Published: 01 November 2007
View articletitled, Activating PIK3CA and AKT mutations in triple-receptor-negative breast cancer